Kuipeng Yu

Jinan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Renal Tubular Epithelial CRLF1 Interacts With ITGB1 to Accelerate Fibrosis During the Transition From AKI to CKD.

Renal Tubular Epithelial CRLF1 Interacts With ITGB1 to Accelerate Fibrosis During the Transition From AKI to CKD.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 02, 2026

DYRK2 drives renal fibrosis through CDK1-dependent G2/M phase dysregulation in tubular epithelial cells.

DYRK2 drives renal fibrosis through CDK1-dependent G2/M phase dysregulation in tubular epithelial cells.

Journal: Cellular & molecular biology letters
Published: November 09, 2025

Effectiveness and safety of finerenone in IgA nephropathy patients.

Effectiveness and safety of finerenone in IgA nephropathy patients.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: May 15, 2025

DUSP5 deficiency suppresses the progression of acute kidney injury by enhancing autophagy through AMPK/ULK1 pathway.

DUSP5 deficiency suppresses the progression of acute kidney injury by enhancing autophagy through AMPK/ULK1 pathway.

Journal: Translational research : the journal of laboratory and clinical medicine
Published: May 26, 2024

Inhibiting ANP32E protects against acute kidney injury by regulating autophagy via the AMPK pathway.

Inhibiting ANP32E protects against acute kidney injury by regulating autophagy via the AMPK pathway.

Journal: iScience
Published: March 15, 2024

Novel biomarkers related to oxidative stress and immunity in chronic kidney disease.

Novel biomarkers related to oxidative stress and immunity in chronic kidney disease.

Journal: Heliyon
Published: February 27, 2024

Blockade of aryl hydrocarbon receptor restricts omeprazole-induced chronic kidney disease.

Blockade of aryl hydrocarbon receptor restricts omeprazole-induced chronic kidney disease.

Journal: Journal of molecular medicine (Berlin, Germany)
Published: May 16, 2023

APOC1 exacerbates renal fibrosis through the activation of the NF-κB signaling pathway in IgAN.

APOC1 exacerbates renal fibrosis through the activation of the NF-κB signaling pathway in IgAN.

Journal: Frontiers in pharmacology
Published: March 07, 2023

APOC1 as a novel diagnostic biomarker for DN based on machine learning algorithms and experiment.

APOC1 as a novel diagnostic biomarker for DN based on machine learning algorithms and experiment.

Journal: Frontiers in endocrinology
Published: November 19, 2022

Identification and validation of P4HB as a novel autophagy-related biomarker in diabetic nephropathy.

Identification and validation of P4HB as a novel autophagy-related biomarker in diabetic nephropathy.

Journal: Frontiers in genetics
Published: June 10, 2022

Hydroxychloroquine alleviates renal interstitial fibrosis by inhibiting the PI3K/Akt signaling pathway.

Hydroxychloroquine alleviates renal interstitial fibrosis by inhibiting the PI3K/Akt signaling pathway.

Journal: Biochemical and biophysical research communications
Published: February 10, 2022

IDO1 as a new immune biomarker for diabetic nephropathy and its correlation with immune cell infiltration.

IDO1 as a new immune biomarker for diabetic nephropathy and its correlation with immune cell infiltration.

Journal: International immunopharmacology
Published: October 08, 2020
Showing 1-12 of 13

Last Updated: 09/26/2026